| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 95 |
| 1 | CETIRIZINE HYDROCHLORIDE | 60 |
| 2 | CETIRIZINE | 40 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 31 |
| 4 | PANTOPRAZOLE | 30 |
| 5 | ADALIMUMAB | 26 |
| 6 | MONTELUKAST SODIUM | 26 |
| 7 | CETIIRIZINE | 24 |
| 8 | METOPROLOL TARTRATE | 24 |
| 9 | DUPILUMAB | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEPIVACAINE HYDROCHLORIDE | 7 | 0.0060 |
| 1 | 12%AZELAIC ACID | 2 | 0.0024 |
| 2 | AZELAIC ACID | 2 | 0.0020 |
| 3 | KETOTIFEN FUMARATE | 11 | 0.0017 |
| 4 | CROMOLYN SODIUM | 6 | 0.0016 |
| 5 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 2 | 0.0016 |
| 6 | NEOMYCIN OINTMENT | 3 | 0.0012 |
| 7 | OMALIZUMAB | 95 | 0.0011 |
| 8 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 9 | REPAGLINIDE | 7 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 95 |
| 1 | Corticosteroid [EPC] | 66 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 33 |
| 5 | Benzodiazepine [EPC] | 23 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 23 |
| 7 | Interleukin-17A Antagonist [EPC] | 17 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 3 | Anti-IgE [EPC] | 95 | 0.0011 |
| 4 | Glinide [EPC] | 7 | 0.0008 |
| 5 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 1 | 0.0005 |
| 6 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 7 | Interleukin-17A Antagonist [EPC] | 17 | 0.0005 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 4 | 0.0004 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 33 | 0.0004 |